InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (5 ops.)
Discover the detailed record of transactions filed by REED ELIZABETH E, General Secretary. Officer active across 1 companies, notably Travere Therapeutics, Inc.. Aggregated, 11 disclosures have been published. Total volume traded: €169k. The latest transaction was filed on 10 May 2022 (Cession). Regulator: SEC (Form 4). The full history is openly available.
Declarations11 total
€18,379900 shares@ €20.42160.0005% mcap10.9% of flow
Common Stock
SEC:0001209191-22-028708:0·
09,840 shares0
Common Stock
SEC:0001209191-22-006369:0·
09,840 shares0
Common Stock
SEC:0001209191-22-006369·
€49,5572,250 shares@ €22.02540.0013% mcap29.4% of flow
Common Stock
SEC:0001209191-22-005081:0·
€49,5572,250 shares@ €22.02540.0013% mcap65.9% of flow
Common Stock
SEC:0001209191-22-005081·
05,000 shares0
Common Stock
SEC:0001209191-22-003053·
05,000 shares0
Common Stock
SEC:0001209191-22-003053:0·
04,500 shares0
Common Stock
SEC:0001209191-21-052078·
04,500 shares0
Common Stock
SEC:0001209191-21-052078:0·
€25,6101,625 shares@ €15.76020.0006% mcap34.1% of flow
Common Stock
SEC:0001209191-21-032316·
€25,6101,625 shares@ €15.76020.0006% mcap15.2% of flow
Common Stock
SEC:0001209191-21-032316:0·
11 of 11 declarations
About REED ELIZABETH E
Elizabeth E. Reed is the Senior Vice President, General Counsel, and Corporate Secretary of Travere Therapeutics, Inc. She oversees the company's legal affairs and compliance. Her role is essential for ensuring legal protection and compliance.
